Empower Women Change the World
Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.
Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora™ as a Contraceptive
September 22, 2015
San Diego, CA — Evofem, Inc. today announced that a New Drug Application for Amphora has been accepted for filing by the United States Food and Drug Administration (FDA). The NDA requests FDA approval for Amphora as a non-hormonal, vaginal gel contraceptive. “We are delighted that the FDA has accepted this filing for Amphora,” said…